However, a previous study has demonstrated significant correlations between CLDN6 expression, molecular subtypes, and clinical characteristics in various adult cancers, particularly in endometrial carcinoma, using transcriptomic data [30]. The gene discussed is CLDN6; the disease is endometrial carcinoma.